Oyster Therapeutics
a pharmaceutical company developing next-generation targeted protein degraders with an initial focus on tau-driven diseases like Alzheimer’s
London, United KingdomBiotechnology
Amount raised
$60M
Round
Series A
Date raised
November 10, 2026
Founded
2020
CompanyOyster Therapeutics
IndustryBiotechnology
LocationLondon, United Kingdom
InvestorsHilal Ventures, 4BIO Capital
Leadership
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About Oyster Therapeutics
a pharmaceutical company developing next-generation targeted protein degraders with an initial focus on tau-driven diseases like Alzheimer’s
- How much did Oyster Therapeutics raise?
- Oyster Therapeutics raised $60M in a Series A round on November 10, 2026. Investors include Hilal Ventures, 4BIO Capital.
- Who runs Oyster Therapeutics?
- Rob Johnson (Chief Executive Officer) is listed as Oyster Therapeutics's officer.
- Where is Oyster Therapeutics based?
- Oyster Therapeutics is based in London, United Kingdom.